First patient with bone marrow cancer treated with CAR-T in Denmark

CITCO has now treated its first multiple myeloma patient with CAR-T cells in a phase III clinical study: CARTITUDE-5.
An important milestone for CITCO has thus been reached.
The patient will also be the first patient with bone marrow cancer to be treated with the new promising treatment in Denmark.